UNSPSC 51314385: Acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE506. This VA Drug Class (RE506) classifies this compound as belonging to the group ANTIHISTAMINE/DECONGESTANT/ANTITUSSIVE/ANALGESIC.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51314385 Acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine is a Commodity code that in practice encompasses generic multi-source pharmaceuticals and over-the-counter (OTC) products procured by state and local health agencies, cooperative purchasing alliances, and county health departments. State and local governments use this code to source individual active pharmaceutical ingredients and combination OTC formulations for public health programs, community health initiatives, and pharmacy benefit administration across multiple jurisdictions. The issuing bodies include state health and human services agencies, county public health departments, and multistate cooperative purchasing organizations that aggregate demand across participating municipalities and state agencies.

Recent activity shows Minnesota's Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 (solicitation S1070000015802, due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products for distribution to state and local government facilities including Oregon, with awards effective July 1, 2026 and a two-year term. Seminole County, Florida issued an IFB in June 2026 (IFB60459723LAS) for naloxone and drug deactivation systems, seeking 1,900 units of naloxone annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The Texas Health and Human Services Commission posted a Request for Information in April 2026 (HHS0017013) to explore direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. Activity is concentrated in the South and Upper Midwest, with MMCAP and Texas HHS driving state-level volume and Seminole County representing county-level community health procurement.